ABBVIE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc.
businesswire.com
news
2022-05-28 00:00:00

May 27, 2022 08:02 PM Eastern Daylight Time NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ('KSF'), announces that KSF has commenced an investigation into AbbVie Inc. (NYSE: ABBV).



Facing the loss of patent protection for its key drug, Humira, in 2023, and the resulting increased competition from generic drug products, throughout the first half of 2021, the Company promoted its drug product, Rinvoq, a Janus kinase ('JAK') inhibitor purposed for the treatment of rheumatoid arthritis ('RA').
